A Review on Newer Ocular Drug Delivery Systems with an Emphasis on Glaucoma
Glaucoma is an irreversible condition resulting from the increase in intraocular pressure (IOP); which leads to permanent loss of vision with the destruction of retinal ganglion cells (RGCs). The IOP elevations are controlled in normal by the physiological flow of aqueous humour. A population with a...
Saved in:
Main Authors: | Maneesha Peter, Rajitha Panonnummal |
---|---|
Format: | article |
Language: | EN |
Published: |
Tabriz University of Medical Sciences
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/4866cba9126d4958a246d2eb9fd64f5b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Topical Medication Therapy for Glaucoma and Ocular Hypertension
by: Tao Wang, et al.
Published: (2021) -
Development of physiologically‐based pharmacokinetic models for standard of care and newer tuberculosis drugs
by: Helen Humphries, et al.
Published: (2021) -
Comparison of clinical effects of two latanoprost 0.005% solutions (Xalatan® and Arulatan®) in primary open-angle glaucoma or ocular hypertensive patients: a randomized clinical trial
by: Brant Fernandes RA, et al.
Published: (2019) -
The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies
by: Davies M, et al.
Published: (2016) -
The Baerveldt Glaucoma Drainage Device: Efficacy, Safety, and Place in Therapy
by: Poelman HJ, et al.
Published: (2020)